| Trial ID: | L0098 |
| Source ID: | NCT02378194
|
| Associated Drug: |
Placebo
|
| Title: |
Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: Placebo|DRUG: HD-003 (800mg/day)|DRUG: HD-003 (1600mg/day)
|
| Outcome Measures: |
Primary: serum creatinine rate inverse number's change, up to 24 weeks|GFR measurements (confirmed by the method MDRD via the value of sCr), up to 24 weeks | Other: Number of Participants with Adverse Events, up to 1 year
|
| Sponsor/Collaborators: |
Sponsor: Hyundai Pharmaceutical Co., LTD.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
62
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-01
|
| Completion Date: |
2013-03
|
| Results First Posted: |
|
| Last Update Posted: |
2017-06-16
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02378194
|
